NONSQUAMOUS NON SMALL CELL LUNG CANCER
Clinical trials for NONSQUAMOUS NON SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NONSQUAMOUS NON SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for NONSQUAMOUS NON SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail aims to stall lung cancer growth
Disease control CompletedThis study tested whether adding a fourth drug, lenvatinib, to a standard three-drug regimen (chemotherapy plus pembrolizumab) could help people with advanced non-squamous lung cancer live longer or keep their cancer from growing. About 761 adults with metastatic disease that had…
Matched conditions: NONSQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New cocktail therapy shows promise for tough lung cancer
Disease control CompletedThis study tested whether adding lenvatinib to standard chemotherapy plus pembrolizumab helps adults from mainland China with advanced nonsquamous non-small cell lung cancer live longer or slow tumor growth. About 200 participants received either the four-drug combo or a placebo …
Matched conditions: NONSQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC